UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Age-related Differences in Recall of Information and Handling of Chemotherapy-related Side Effects in Cancer Patients: The ReCap Study

The oncologist (Dayton, Ohio), 2022-03, Vol.27 (2), p.e185-e193

2022

Volltextzugriff (PDF)

Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer

Journal of clinical oncology, 2014-01, Vol.32 (2), p.76-82

2014

Volltextzugriff (PDF)

Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

Journal of clinical oncology, 2005-07, Vol.23 (21), p.4602-4608

2005

Volltextzugriff (PDF)

7105 POSTER DISCUSSION Belinostat in Combination With Carboplatin and Paclitaxel (BelCaP) for Treatment of Bladder Cancer – A Pharmacokinetic Study of Exposure to Belinostat and Its Metabolites

European journal of cancer (1990), 2011, Vol.47, p.S506-S506

2011

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy

Annals of oncology, 2017-11, Vol.28 (11), p.2741-2746

2017

Volltextzugriff (PDF)

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

The lancet oncology, 2014-06, Vol.15 (7), p.700-712

2014

Volltextzugriff (PDF)

Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma

Radiotherapy and oncology, 2005-07, Vol.76 (1), p.48-53

2005

Volltextzugriff (PDF)

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

Annals of oncology, 2006-05, Vol.17 (suppl-5), p.v118-v122

2006

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data

European urology, 2005-08, Vol.48 (2), p.202-206

Vale, C.L.

2005

Volltextzugriff (PDF)

Adjuvant Chemotherapy in Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data

European urology, 2005-08, Vol.48 (2), p.189-201

Vale, Claire L.

2005

Volltextzugriff (PDF)

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

The Lancet (British edition), 2003-06, Vol.361 (9373), p.1927-1934

Vale, C

2003

Volltextzugriff (PDF)

Cabazitaxel vs docetaxel in chemotherapy-naive (CN) patients with metastatic castration-resistant prostate cancer (mCRPC): A three-arm phase III study (FIRSTANA)

JOURNAL OF CLINICAL ONCOLOGY, 2016, Vol.34 (15_suppl), p.5006-5006

2016

Volltextzugriff (PDF)

Predictive factors of response to cisplatin-based chemotherapy and the relation of response to survival in patients with metastatic urothelial cancer

Cancer chemotherapy and pharmacology, 2000, Vol.46 (5), p.357-364

2000

Volltextzugriff (PDF)

Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer : A prospective study with more than 10 years of follow up

Breast cancer research and treatment, 1997-09, Vol.45 (2), p.181-192

1997

Volltextzugriff (PDF)

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of invasive bladder cancer

Annals of oncology, 2003-07, Vol.14 (7), p.1008-1009

Sengeløv, L

2003

Volltextzugriff (PDF)

Tolerability of Cabazitaxel in Senior Adults with Metastatic Castration-Resistant Prostate Cancer (MCRPC) in Europe

Annals of oncology, 2012-09, Vol.23, p.ix307

2012

Volltextzugriff (PDF)

Radiotherapy in bladder cancer

Radiotherapy and Oncology, 1999-07, Vol.52 (1), p.1-14

1999

Volltextzugriff (PDF)

Docetaxel and cisplatin in metastatic urothelial cancer: a phase II study

Journal of clinical oncology, 1998-10, Vol.16 (10), p.3392-3397

1998

Volltextzugriff (PDF)

ASSESSMENT OF PATIENTS WITH METASTATIC TRANSITIONAL CELL CARCINOMA OF THE URINARY TRACT

The Journal of urology, 1999-08, Vol.162 (2), p.343-346

1999

Volltextzugriff (PDF)

Neoadjuvant chemotherapy for invasive bladder cancer

Cochrane database of systematic reviews, 2005-04 (2), p.CD005246

Advanced Bladder Cancer Overview Collaboration

2005

Volltextzugriff (PDF)

Adjuvant chemotherapy for invasive bladder cancer (individual patient data)

Cochrane database of systematic reviews, 2006-04, Vol.2011 (2), p.CD006018

Vale, Claire L

2006

Volltextzugriff (PDF)

Treatment outcome following radiotherapy in elderly patients with bladder cancer

Radiotherapy and oncology, 1997-07, Vol.44 (1), p.53-58

1997

Volltextzugriff (PDF)

Pattern of Metastases in Relation to Characteristics of Primary Tumor and Treatment in Patients with Disseminated Urothelial Carcinoma

The Journal of urology, 1996, Vol.155 (1), p.111-114

1996

Volltextzugriff (PDF)

106 Cabazitaxel adverse events are manageable in senior adults with metastatic castration-resistant prostate cancer (mCRPC): Results of the European Compassionate Use Programme

European urology supplements : official journal of the European Association of Urology, 2013-03, Vol.12 (1), p.e106-e107

2013

Volltextzugriff (PDF)

Metastatic Urothelial Cancer: Evaluation of Prognostic Factors and Change in Prognosis during the Last Twenty Years

European urology, 2001-06, Vol.39 (6), p.634-642

2001

Volltextzugriff (PDF)

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(132)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(90)
Life Sciences & Biomedicine
(90)
Science & Technology
(90)
Biological And Medical Sciences
(53)
Middle Aged
(49)
Male
(48)
Female
(45)
Oncology
(38)
Aged
(37)
Medical Sciences
(32)
Adult
(31)
Hematology
(31)
Chemotherapy
(23)
Fundamental And Applied Biological Sciences. Psychology
(21)
Immunology
(19)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Neutrophils - Ultrastructure
(15)
Survival Analysis
(15)
Urinary Bladder Neoplasms - Drug Therapy
(15)
Cancer
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Age-related Differences in Recall of Information and Handling of Chemotherapy-related Side Effects in Cancer Patients: The ReCap Study

Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer

Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

7105 POSTER DISCUSSION Belinostat in Combination With Carboplatin and Paclitaxel (BelCaP) for Treatment of Bladder Cancer – A Pharmacokinetic Study of Exposure to Belinostat and Its Metabolites

A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data

Adjuvant Chemotherapy in Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

Cabazitaxel vs docetaxel in chemotherapy-naive (CN) patients with metastatic castration-resistant prostate cancer (mCRPC): A three-arm phase III study (FIRSTANA)

Predictive factors of response to cisplatin-based chemotherapy and the relation of response to survival in patients with metastatic urothelial cancer

Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer : A prospective study with more than 10 years of follow up

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of invasive bladder cancer

Tolerability of Cabazitaxel in Senior Adults with Metastatic Castration-Resistant Prostate Cancer (MCRPC) in Europe

Radiotherapy in bladder cancer

Docetaxel and cisplatin in metastatic urothelial cancer: a phase II study

ASSESSMENT OF PATIENTS WITH METASTATIC TRANSITIONAL CELL CARCINOMA OF THE URINARY TRACT

Neoadjuvant chemotherapy for invasive bladder cancer

Adjuvant chemotherapy for invasive bladder cancer (individual patient data)

Treatment outcome following radiotherapy in elderly patients with bladder cancer

Pattern of Metastases in Relation to Characteristics of Primary Tumor and Treatment in Patients with Disseminated Urothelial Carcinoma

106 Cabazitaxel adverse events are manageable in senior adults with metastatic castration-resistant prostate cancer (mCRPC): Results of the European Compassionate Use Programme

Metastatic Urothelial Cancer: Evaluation of Prognostic Factors and Change in Prognosis during the Last Twenty Years

Suchergebnisse filtern